AAAAAA
Results: 1-25/50
Authors:
TU JL
GOLDE DW
VERA JC
HEANEY ML
Citation: Jl. Tu et al., EXPRESSION OF THE HUMAN GM-CSF RECEPTOR-ALPHA SUBUNIT IN SACCHAROMYCES-CEREVISIAE, Cytokines cellular & molecular therapy, 4(3), 1998, pp. 147-151
Authors:
REVELLI S
DIDOLI G
ROGGERO E
MORENO H
BERNABO J
WIETZERBIN J
BOTTASSO O
Citation: S. Revelli et al., MACROPHAGE ACTIVITY, IL-6 LEVELS, ANTIBODY-RESPONSE AND HEART HISTOLOGY IN RATS UNDERGOING AN ATTENUATED TRYPANOSOMA-CRUZI ACUTE INFECTION UPON TREATMENT WITH RECOMBINANT INTERFERON-GAMMA, Cytokines cellular & molecular therapy, 4(3), 1998, pp. 153-159
Authors:
NAGLER A
BISHARA A
BRAUTBAR C
BARAK V
Citation: A. Nagler et al., DYSREGULATION OF INFLAMMATORY CYTOKINES IN UNRELATED BONE-MARROW TRANSPLANTATION, Cytokines cellular & molecular therapy, 4(3), 1998, pp. 161-167
Authors:
NANDAKUMAR KS
VARALAKSHMI C
KHAR A
Citation: Ks. Nandakumar et al., ROLE OF CYTOKINES IN THE MAINTENANCE OF THE MEMORY IMMUNE-RESPONSE INDUCED BY A RAT HISTIOCYTOMA IN SYNGENEIC HOSTS, Cytokines cellular & molecular therapy, 4(3), 1998, pp. 169-175
Authors:
SODDU S
SACCHI A
Citation: S. Soddu et A. Sacchi, P53 - PROSPECTS FOR CANCER GENE-THERAPY, Cytokines cellular & molecular therapy, 4(3), 1998, pp. 177-185
Authors:
BRUSERUD O
Citation: O. Bruserud, IL-4, IL-10 AND IL-13 IN ACUTE MYELOGENOUS LEUKEMIA, Cytokines cellular & molecular therapy, 4(3), 1998, pp. 187-198
Authors:
TOREN A
NAGLER A
Citation: A. Toren et A. Nagler, THE IMPLICATIONS OF GRANULOCYTE-MONOCYTE COLONY-STIMULATING FACTOR (GM-CSF) IN CYTOTOXICITY OF BONE-MARROW TRANSPLANTATION, Cytokines cellular & molecular therapy, 4(3), 1998, pp. 199-206
Authors:
BENVENISTE O
MARTIN M
VILLINGER F
DORMONT D
Citation: O. Benveniste et al., TECHNIQUES FOR QUANTIFICATION OF CYTOKINE MESSENGER-RNAS, Cytokines cellular & molecular therapy, 4(3), 1998, pp. 207-214
Authors:
FADERL S
ESTROV Z
Citation: S. Faderl et Z. Estrov, RESIDUAL DISEASE IN ACUTE LYMPHOBLASTIC-LEUKEMIA OF CHILDHOOD - METHODS OF DETECTION AND CLINICAL RELEVANCE, Cytokines cellular & molecular therapy, 4(2), 1998, pp. 73-85
Authors:
MORECKI S
LUBINASALOMON A
SLAVIN S
NAGLER A
Citation: S. Morecki et al., CYTOKINE GENE TRANSDUCTION INTO NON-IMMUNOGENEIC MURINE TUMOR-CELLS, Cytokines cellular & molecular therapy, 4(2), 1998, pp. 87-94
Authors:
KIRCHEIS R
KUPCU Z
WALLNER G
WAGNER E
Citation: R. Kircheis et al., CYTOKINE GENE-MODIFIED TUMOR-CELLS FOR PROPHYLACTIC AND THERAPEUTIC VACCINATION - IL-2, IFN-GAMMA, OR COMBINATION IL-2-GAMMA(IFN), Cytokines cellular & molecular therapy, 4(2), 1998, pp. 95-103
Authors:
TOOSSI Z
Citation: Z. Toossi, ADJUNCTIVE IMMUNOTHERAPY OF TUBERCULOSIS, Cytokines cellular & molecular therapy, 4(2), 1998, pp. 105-112
Authors:
TACHIBANA M
MURAI M
Citation: M. Tachibana et M. Murai, G-CSF PRODUCTION IN HUMAN BLADDER-CANCER AND ITS ABILITY TO PROMOTE AUTOCRINE GROWTH - A REVIEW, Cytokines cellular & molecular therapy, 4(2), 1998, pp. 113-120
Authors:
FREEDMAN RS
LENZI R
KUDELKA AP
LAWRENCE DD
ROSENBLUM M
PLATSOUCAS CD
Citation: Rs. Freedman et al., INTRAPERITONEAL IMMUNOTHERAPY OF PERITONEAL CARCINOMATOSIS, Cytokines cellular & molecular therapy, 4(2), 1998, pp. 121-140
Authors:
OR R
ACKERSTEIN A
NAGLER A
KAPELUSHNIK J
NAPARSTEK E
SAMUEL S
AMAR A
BRUATBAR C
SLAVIN S
Citation: R. Or et al., ALLOGENEIC CELL-MEDIATED IMMUNOTHERAPY FOR BREAST-CANCER AFTER AUTOLOGOUS STEM-CELL TRANSPLANTATION - A CLINICAL PILOT-STUDY, Cytokines cellular & molecular therapy, 4(1), 1998, pp. 1-6
Authors:
LANGABEER SE
LINCH DC
Citation: Se. Langabeer et Dc. Linch, IL-1 RECEPTOR ANTAGONIST GENE POLYMORPHISM IN PATIENTS WITH SECONDARYACUTE MYELOID-LEUKEMIA, Cytokines cellular & molecular therapy, 4(1), 1998, pp. 7-9
Authors:
ZHAO XX
LIAO MJ
RASHIDBAIGI A
Citation: Xx. Zhao et al., INHIBITORY EFFECT OF INTERLEUKIN-10 ON HUMAN-LEUKOCYTE INTERFERON-ALPHA PRODUCTION BY SENDAI VIRUS, Cytokines cellular & molecular therapy, 4(1), 1998, pp. 11-16
Authors:
MILES S
LEVINE A
FELDSTEIN M
CARDEN J
CABRIALLAS S
MARCUS S
MITSUYASU R
GILL P
Citation: S. Miles et al., OPEN-LABEL PHASE-I STUDY OF COMBINATION THERAPY WITH ZIDOVUDINE AND INTERFERON-BETA IN PATIENTS WITH AIDS-RELATED KAPOSIS-SARCOMA - AIDS CLINICAL-TRIALS GROUP PROTOCOL-057, Cytokines cellular & molecular therapy, 4(1), 1998, pp. 17-23
Authors:
ALEXANDER WS
BEGLEY CG
Citation: Ws. Alexander et Cg. Begley, THROMBOPOIETIN IN-VITRO AND IN-VIVO, Cytokines cellular & molecular therapy, 4(1), 1998, pp. 25-34
Authors:
MORSE MA
LYERLY HK
Citation: Ma. Morse et Hk. Lyerly, IMMUNOTHERAPY OF CANCER USING DENDRITIC CELLS, Cytokines cellular & molecular therapy, 4(1), 1998, pp. 35-44
Authors:
IWAHASHI H
ITOH N
YAMAGATA K
IMAGAWA A
NAKAJIMA H
TOMITA K
MORIWAKI M
WAGURI M
YAMAMOTO K
MIYAGAWA J
NAMBA M
HANAFUSA T
MATSUZAWA Y
Citation: H. Iwahashi et al., MOLECULAR MECHANISMS OF PANCREATIC BETA-CELL DESTRUCTION IN AUTOIMMUNE DIABETES - POTENTIAL TARGETS FOR PREVENTIVE THERAPY, Cytokines cellular & molecular therapy, 4(1), 1998, pp. 45-51
Authors:
FERNANDEZ N
DUFFOUR MT
PERRICAUDET M
LOTZE MT
TURSZ T
ZITVOGEL L
Citation: N. Fernandez et al., ACTIVE SPECIFIC T-CELL-BASED IMMUNOTHERAPY FOR CANCER - NUCLEIC-ACIDS, PEPTIDES, WHOLE NATIVE PROTEINS, RECOMBINANT VIRUSES, WITH DENDRITICCELL ADJUVANTS OR WHOLE TUMOR CELL-BASED VACCINES - PRINCIPLES AND FUTURE-PROSPECTS, Cytokines cellular & molecular therapy, 4(1), 1998, pp. 53-65
Authors:
LIO D
CANDORE G
ROMANO GC
DANNA C
GERVASI F
DILORENZO G
MODICA MA
POTESTIO M
CARUSO C
Citation: D. Lio et al., MODIFICATION OF CYTOKINE PATTERNS IN SUBJECTS BEARING THE HLA-B8,DR3 PHENOTYPE - IMPLICATIONS FOR AUTOIMMUNITY, Cytokines cellular & molecular therapy, 3(4), 1997, pp. 217-223
Authors:
NANDAKUMAR KS
KUMARI AL
KHAR A
Citation: Ks. Nandakumar et al., EARLY EXPRESSION OF INTERLEUKIN-12, P40 SUBUNIT AND IFN-GAMMA INHIBITS REGRESSION OF AK-5 TUMOR, Cytokines cellular & molecular therapy, 3(4), 1997, pp. 225-232
Authors:
BREWER JM
ALEXANDER J
Citation: Jm. Brewer et J. Alexander, CYTOKINES AND THE MECHANISMS OF ACTION OF VACCINE ADJUVANTS, Cytokines cellular & molecular therapy, 3(4), 1997, pp. 233-246